Neuphoria Therapeutics Inc (NEUP) — Capital Reinvestment Ratio
Latest as of June 2025:
0.00x
Neuphoria Therapeutics Inc (NEUP) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow ($73.57 Million) in capital expenditures ($3.00). See how much free cash does Neuphoria Therapeutics Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$73.57 Million
USD
Capital Expenditures
$3.00
USD
Data as of
Jun 2025
Most recent filing
Neuphoria Therapeutics Inc Capital Reinvestment Ratio (2015–2015)
This chart tracks Neuphoria Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Neuphoria Therapeutics Inc (2015–2015)
Year-by-year Capital Reinvestment Ratio for Neuphoria Therapeutics Inc from 2015 to 2015. For live market cap and broader valuation context, see Neuphoria Therapeutics Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 0.13x | $4.94 Million | $649.08K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow